J. Paul Branthwaite, BSc MIOD

Senior Partner

Email: paul.branthwaite@transcrip-partners.com

Paul has spent many years assessing and consulting on Client needs and has lectured internationally on this critical area. His perspective on how to accurately break down projects into the various component parts is based on nearly 30 years of 'hands-on' experience within 3 mainstream pharma groups; 2 CROs, 3 consultancies and a biotech. He now leads the TranScrip business development and client interface programmes.

Since graduating in Pharmacology in 1979, Paul has held many roles within the pharmaceutical industry, including in marketing, in business development and clinical R&D. His therapeutic focus has spanned into cardiovascular, dermatology, immunology, neuro-endocrine, anti-infectives, and CNS, as well as pain, wound-healing and oncology disease areas. Notably, Paul was part of the launch team for cyclosporin A in transplantation (with Sandoz), where he made the unusual transition to clinical research, working with that drug in autoimmune indications. He subsequently spent 12 years in operational and managerial roles within clinical development and medical affairs. Paul led business development efforts and global clinical programmes for two CROs, as well as running UK clinical operations for a Swedish biotech.